This study has been approved by the IRB of DongShin University Gwangju Korean Medicine Hospital, Republic of Korea (DSUOH-051). The purpose and potential risks of this clinical trial will be fully explained to the participants and their families. All participants will be asked to provide written informed consent before participation.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.